Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents.

MLA

Bar-Yehuda, Sara, et al. “Agonists to the A3 Adenosine Receptor Induce G-CSF Production via NF-KappaB Activation: A New Class of Myeloprotective Agents.” Experimental Hematology, vol. 30, no. 12, Dec. 2002, pp. 1390–98. EBSCOhost, https://doi.org/10.1016/s0301-472x(02)00962-1.

APA

Bar-Yehuda, S., Madi, L., Barak, D., Mittelman, M., Ardon, E., Ochaion, A., Cohn, S., & Fishman, P. (2002). Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents. Experimental Hematology, 30(12), 1390–1398. https://doi.org/10.1016/s0301-472x(02)00962-1

Chicago

Bar-Yehuda, Sara, Lea Madi, Dana Barak, Moshe Mittelman, Eti Ardon, Avivit Ochaion, Shira Cohn, and Pnina Fishman. 2002. “Agonists to the A3 Adenosine Receptor Induce G-CSF Production via NF-KappaB Activation: A New Class of Myeloprotective Agents.” Experimental Hematology 30 (12): 1390–98. doi:10.1016/s0301-472x(02)00962-1.